GME
50
-2
COP
50
3
UA
3
-17
NWS
58
-6
ORLY
73
11
SWKS
40
-4
CVS
68
4
EXR
20
-2
APD
47
2
LB
12
2
FITB
50
-8
BBY
50
-3
BA
35
2
INTC
39
2
EMN
35
2
PRU
50
3
EIX
56
-5
INTU
54
-2
CTSH
35
2
PNC
55
3
GME
50
-2
COP
50
3
UA
3
-17
NWS
58
-6
ORLY
73
11
SWKS
40
-4
CVS
68
4
EXR
20
-2
APD
47
2
LB
12
2
FITB
50
-8
BBY
50
-3
BA
35
2
INTC
39
2
EMN
35
2
PRU
50
3
EIX
56
-5
INTU
54
-2
CTSH
35
2
PNC
55
3
Financhill
Back

Workday Vs. Kymera Therapeutics Industry Stock Comparison

Sell
28

WDAY
Workday

Last Price:
$222.12
Seasonality Move:
3.44%
Sell
39

KYMR
Kymera Therapeutics

Last Price:
$40.64
Seasonality Move:
-2.33%
Sell
28
Workday (WDAY) is a Sell

Is Workday a Buy, Sell or Hold?

  • The current Workday [WDAY] share price is $222.07. The Score for WDAY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • WDAY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Kymera Therapeutics (KYMR) is a Sell

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $40.62. The Score for KYMR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • KYMR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

WDAY Stock Price Chart

What is Workday's stock price today?

  • The Workday share price today is $222.07
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WDAY is experiencing buying pressure, which is a positive indicator for future bullish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $40.62
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

WDAY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 62.3 Buy
Relative Strength Index (14 RSI): 38.59 Sell
Chaikin Money Flow: 2297159 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (224.8 - 238.94) Sell
Bollinger Bands (100): (226.89 - 254.97) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 11.58 Buy
Relative Strength Index (14 RSI): 33.78 Sell
Chaikin Money Flow: 484697 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.69 - 45.87) Sell
Bollinger Bands (100): (28.55 - 45.29) Buy

WDAY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 226.44 Sell
20-day SMA: 231.12 Sell
50-day SMA: 237.91 Sell
200-day SMA: 249.41 Sell
8-day EMA: 201.73 Buy
20-day EMA: 134.58 Buy
50-day EMA: 68.75 Buy
200-day EMA: 19.6 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.53 Sell
20-day SMA: 44.25 Sell
50-day SMA: 44.48 Sell
200-day SMA: 39.27 Buy
8-day EMA: 37.55 Buy
20-day EMA: 25.15 Buy
50-day EMA: 12.86 Buy
200-day EMA: 3.67 Buy

Workday Earnings Growth & WDAY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.40 per share, an increase next quarter of $0.29 per share, an increase this year of $1.43 per share, and an increase next year of $1.58 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.18 per share, a decrease this year of $0.65 per share, and a decrease next year of $0.51 per share.

Workday Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):